Oliver Söhnlein is Professor for Vascular Immunotherapy at the Ludwig-Maximilians-Universität in Munich, within the DZHK, the German Centre for Cardiovascular Research, and holds a guest professorship for Inflammation Physiology at the Karolinska Institutet, Stockholm, Sweden. His research focuses on the role of myeloid cells in vascular inflammation.
Our mission: To reduce the burden of cardiovascular disease.